{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:26:24Z","timestamp":1788999984978,"version":"build-2803163510"},"reference-count":52,"publisher":"American Diabetes Association","issue":"11","license":[{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":4317,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,11,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>During hypoinsulinemia, when cardiac glucose utilization is impaired, the heart rapidly adapts to using more fatty acids. One means by which this is achieved is through lipoprotein lipase (LPL). We determined the mechanisms by which the heart regulates LPL after acute hypoinsulinemia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>We used two different doses of streptozocin (55 [d-55] and 100 [d-100] mg\/kg) to induce moderate and severe hypoinsulinemia, respectively, in rats. Isolated cardiomyocytes were also used for transfection or silencing of protein kinase D (PKD) and caspase-3.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>There was substantial increase in LPL in d-55 hearts, an effect that was absent in severely hypoinsulinemic d-100 animals. Measurement of PKD, a key element involved in increasing LPL, revealed that only d-100 hearts showed an increase in proteolysis of PKD, an effect that required activation of caspase-3 together with loss of 14-3-3\u03b6, a binding protein that protects enzymes against degradation. In vitro, phosphomimetic PKD colocalized with LPL in the trans-golgi. PKD, when mutated to prevent its cleavage by caspase-3 and silencing of caspase-3, was able to increase LPL activity. Using a caspase inhibitor (Z-DEVD) in d-100 animals, we effectively lowered caspase-3 activity, prevented PKD cleavage, and increased LPL vesicle formation and translocation to the vascular lumen. This increase in cardiac luminal LPL was associated with a striking accumulation of cardiac triglyceride in Z-DEVD\u2013treated d-100 rats.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>After severe hypoinsulinemia, activation of caspase-3 can restrict LPL translocation to the vascular lumen. When caspase-3 is inhibited, this compensatory response is lost, leading to lipid accumulation in the heart.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/db09-0681","type":"journal-article","created":{"date-parts":[[2009,10,29]],"date-time":"2009-10-29T16:59:52Z","timestamp":1256835592000},"page":"2464-2475","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":31,"title":["Cleavage of Protein Kinase D After Acute Hypoinsulinemia Prevents Excessive Lipoprotein Lipase\u2013Mediated Cardiac Triglyceride Accumulation"],"prefix":"10.2337","volume":"58","author":[{"given":"Min Suk","family":"Kim","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanth","family":"Puthanveetil","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Kewalramani","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Innis","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Marzban","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan F.","family":"Steinberg","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Columbia University, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis D.","family":"Webber","sequence":"additional","affiliation":[{"name":"Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, British Columbia, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Kieffer","sequence":"additional","affiliation":[{"name":"Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, British Columbia, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Abrahani","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031210523488100_B1","first-page":"E606","article-title":"Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease","volume":"258","author":"Avogaro","year":"1990","journal-title":"Am J Physiol"},{"key":"2022031210523488100_B2","doi-asserted-by":"crossref","first-page":"8162","DOI":"10.1016\/S0021-9258(18)92956-X","article-title":"Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts","volume":"266","author":"Saddik","year":"1991","journal-title":"J Biol Chem"},{"key":"2022031210523488100_B3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0005-2760(94)00082-4","article-title":"Regulation of fatty acid oxidation in the mammalian heart in health and disease","volume":"1213","author":"Lopaschuk","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"2022031210523488100_B4","first-page":"H1084","article-title":"Endogenous triacylglycerol metabolism in diabetic heart","volume":"242","author":"Paulson","year":"1982","journal-title":"Am J Physiol"},{"key":"2022031210523488100_B5","doi-asserted-by":"crossref","first-page":"55i","DOI":"10.1016\/S0002-9149(02)02634-6","article-title":"Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance","volume":"90","author":"Haffner","year":"2002","journal-title":"Am J Cardiol"},{"key":"2022031210523488100_B6","first-page":"E818","article-title":"Lipoprotein lipase in myocytes and capillary endothelium of heart: immunocytochemical study","volume":"256","author":"Blanchette-Mackie","year":"1989","journal-title":"Am J Physiol"},{"key":"2022031210523488100_B7","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1194\/jlr.R200015-JLR200","article-title":"Lipoprotein lipase: genetics, lipid uptake, and regulation","volume":"43","author":"Merkel","year":"2002","journal-title":"J Lipid Res"},{"key":"2022031210523488100_B8","doi-asserted-by":"crossref","first-page":"E331","DOI":"10.1152\/ajpendo.00298.2002","article-title":"Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA","volume":"284","author":"Augustus","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031210523488100_B9","doi-asserted-by":"crossref","first-page":"C673","DOI":"10.1152\/ajpcell.1990.258.4.C673","article-title":"Lipoprotein lipase: cellular origin and functional distribution","volume":"258","author":"Camps","year":"1990","journal-title":"Am J Physiol"},{"key":"2022031210523488100_B10","first-page":"1060","article-title":"Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases","volume":"320","author":"Eckel","year":"1989","journal-title":"N Engl J Med"},{"key":"2022031210523488100_B11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/aja.1001850218","article-title":"Cytochemical studies of lipid metabolism: immunogold probes for lipoprotein lipase and cholesterol","volume":"185","author":"Blanchette-Mackie","year":"1989","journal-title":"Am J Anat"},{"key":"2022031210523488100_B12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0022-2828(08)80016-8","article-title":"Myocardial substrate metabolism: implications for diabetic cardiomyopathy","volume":"27","author":"Rodrigues","year":"1995","journal-title":"J Mol Cell Cardiol"},{"key":"2022031210523488100_B13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0022-2828(03)00205-0","article-title":"Evidence for rapid \u201cmetabolic switching\u201d through lipoprotein lipase occupation of endothelial-binding sites","volume":"35","author":"Pulinilkunnil","year":"2003","journal-title":"J Mol Cell Cardiol"},{"key":"2022031210523488100_B14","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.2337\/diab.46.8.1346","article-title":"Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity","volume":"46","author":"Rodrigues","year":"1997","journal-title":"Diabetes"},{"key":"2022031210523488100_B15","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0008-6363(03)00469-3","article-title":"Circulating triglyceride lipolysis facilitates lipoprotein lipase translocation from cardiomyocyte to myocardial endothelial lining","volume":"59","author":"Pulinilkunnil","year":"2003","journal-title":"Cardiovasc Res"},{"key":"2022031210523488100_B16","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1161\/01.ATV.19.6.1526","article-title":"Localization of lipoprotein lipase in the diabetic heart: regulation by acute changes in insulin","volume":"19","author":"Sambandam","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031210523488100_B17","doi-asserted-by":"crossref","first-page":"H1874","DOI":"10.1152\/ajpheart.2000.278.6.H1874","article-title":"Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts","volume":"278","author":"Sambandam","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022031210523488100_B18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/CIRCRESAHA.108.178681","article-title":"Protein kinase D is a key regulator of cardiomyocyte lipoprotein lipase secretion after diabetes","volume":"103","author":"Kim","year":"2008","journal-title":"Circ Res"},{"key":"2022031210523488100_B19","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1152\/ajpendo.00211.2004","article-title":"The metabolic \u201cswitch\u201d AMPK regulates cardiac heparin-releasable lipoprotein lipase","volume":"288","author":"An","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031210523488100_B20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2337\/db07-0832","article-title":"Acute diabetes moderates trafficking of cardiac lipoprotein lipase through p38 mitogen-activated protein kinase-dependent actin cytoskeleton organization","volume":"57","author":"Kim","year":"2008","journal-title":"Diabetes"},{"key":"2022031210523488100_B21","doi-asserted-by":"crossref","first-page":"15753","DOI":"10.1074\/jbc.272.25.15753","article-title":"Endothelial cell heparanase modulation of lipoprotein lipase activity. Evidence that heparan sulfate oligosaccharide is an extracellular chaperone","volume":"272","author":"Pillarisetti","year":"1997","journal-title":"J Biol Chem"},{"key":"2022031210523488100_B22","doi-asserted-by":"crossref","first-page":"H1108","DOI":"10.1152\/ajpheart.01312.2008","article-title":"Endothelial heparanase secretion after acute hypoinsulinemia is regulated by glucose and fatty acid","volume":"296","author":"Wang","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022031210523488100_B23","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1172\/JCI106180","article-title":"Diabetogenic action of streptozotocin: relationship of dose to metabolic response","volume":"48","author":"Junod","year":"1969","journal-title":"J Clin Invest"},{"key":"2022031210523488100_B24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.yjmcc.2006.11.010","article-title":"AMPK control of myocardial fatty acid metabolism fluctuates with the intensity of insulin-deficient diabetes","volume":"42","author":"Kewalramani","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"2022031210523488100_B25","first-page":"E477","article-title":"Diabetes reduces heparin- and phospholipase C-releasable lipoprotein lipase from cardiomyocytes","volume":"260","author":"Braun","year":"1991","journal-title":"Am J Physiol"},{"key":"2022031210523488100_B26","doi-asserted-by":"crossref","first-page":"18476","DOI":"10.1074\/jbc.M002266200","article-title":"Proteolytic cleavage and activation of protein kinase C [micro] by caspase-3 in the apoptotic response of cells to 1-\u03b2-D-arabinofuranosylcytosine and other genotoxic agents","volume":"275","author":"Endo","year":"2000","journal-title":"J Biol Chem"},{"key":"2022031210523488100_B27","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1093\/emboj\/20.21.5982","article-title":"Recruitment of protein kinase D to the trans-Golgi network via the first cysteine-rich domain","volume":"20","author":"Maeda","year":"2001","journal-title":"Embo J"},{"key":"2022031210523488100_B28","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1074\/jbc.R100059200","article-title":"14\u20133-3 proteins: active cofactors in cellular regulation by serine\/threonine phosphorylation","volume":"277","author":"Tzivion","year":"2002","journal-title":"J Biol Chem"},{"key":"2022031210523488100_B29","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00125-005-1774-7","article-title":"Expression of 14\u20133-3 zeta and interaction with protein kinase C in the rat retina in early diabetes","volume":"48","author":"Kim","year":"2005","journal-title":"Diabetologia"},{"key":"2022031210523488100_B30","doi-asserted-by":"crossref","first-page":"26543","DOI":"10.1074\/jbc.274.37.26543","article-title":"Characterization of Ser916 as an in vivo autophosphorylation site for protein kinase D\/Protein kinase Cmu","volume":"274","author":"Matthews","year":"1999","journal-title":"J Biol Chem"},{"key":"2022031210523488100_B31","doi-asserted-by":"crossref","first-page":"20245","DOI":"10.1074\/jbc.272.32.20245","article-title":"Bryostatin 1 induces biphasic activation of protein kinase D in intact cells","volume":"272","author":"Matthews","year":"1997","journal-title":"J Biol Chem"},{"key":"2022031210523488100_B32","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.cellsig.2006.10.012","article-title":"Protein kinase D 3 is localized in vesicular structures and interacts with vesicle-associated membrane protein 2","volume":"19","author":"Lu","year":"2007","journal-title":"Cell Signal"},{"key":"2022031210523488100_B33","doi-asserted-by":"crossref","first-page":"H1489","DOI":"10.1152\/ajpheart.00278.2006","article-title":"Role of changes in cardiac metabolism in development of diabetic cardiomyopathy","volume":"291","author":"An","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022031210523488100_B34","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2337\/diabetes.51.6.1938","article-title":"Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway","volume":"51","author":"Cai","year":"2002","journal-title":"Diabetes"},{"key":"2022031210523488100_B35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","article-title":"Emerging roles of caspase-3 in apoptosis","volume":"6","author":"Porter","year":"1999","journal-title":"Cell Death Differ"},{"key":"2022031210523488100_B36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.tcb.2007.01.001","article-title":"Nonapoptotic functions of caspases: caspases as regulatory molecules for immunity and cell-fate determination","volume":"17","author":"Kuranaga","year":"2007","journal-title":"Trends Cell Biol"},{"key":"2022031210523488100_B37","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1073\/pnas.96.6.3165","article-title":"Induced mutant mouse lines that express lipoprotein lipase in cardiac muscle, but not in skeletal muscle and adipose tissue, have normal plasma triglyceride and high-density lipoprotein-cholesterol levels","volume":"96","author":"Levak-Frank","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022031210523488100_B38","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1172\/JCI118145","article-title":"Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice","volume":"96","author":"Levak-Frank","year":"1995","journal-title":"J Clin Invest"},{"key":"2022031210523488100_B39","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.2337\/db06-0399","article-title":"OXPAT\/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization","volume":"55","author":"Wolins","year":"2006","journal-title":"Diabetes"},{"key":"2022031210523488100_B40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1172\/JCI16751","article-title":"Lipoprotein lipase (LPL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy","volume":"111","author":"Yagyu","year":"2003","journal-title":"J Clin Invest"},{"key":"2022031210523488100_B41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cellsig.2007.11.007","article-title":"Identification of protein kinase D as a novel contraction-activated kinase linked to GLUT4-mediated glucose uptake, independent of AMPK","volume":"20","author":"Luiken","year":"2008","journal-title":"Cell Signal"},{"key":"2022031210523488100_B42","first-page":"H837","article-title":"Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy","volume":"264","author":"Garvey","year":"1993","journal-title":"Am J Physiol"},{"key":"2022031210523488100_B43","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s00125-004-1429-0","article-title":"Overexpression of lipoprotein lipase improves insulin resistance induced by a high-fat diet in transgenic rabbits","volume":"47","author":"Kitajima","year":"2004","journal-title":"Diabetologia"},{"key":"2022031210523488100_B44","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1073\/pnas.121164498","article-title":"Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance","volume":"98","author":"Kim","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022031210523488100_B45","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2337\/db07-1839","article-title":"Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues","volume":"58","author":"Wang","year":"2009","journal-title":"Diabetes"},{"key":"2022031210523488100_B46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10557-008-6115-x","article-title":"Antiapoptosis and mitochondrial effect of pioglitazone preconditioning in the ischemic\/reperfused heart of rat","volume":"22","author":"Li","year":"2008","journal-title":"Cardiovasc Drugs Ther"},{"key":"2022031210523488100_B47","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0149-2918(02)85040-8","article-title":"Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical records","volume":"24","author":"Boyle","year":"2002","journal-title":"Clin Ther"},{"key":"2022031210523488100_B48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1365-2125.1999.00920.x","article-title":"Effect of troglitazone on plasma lipid metabolism and lipoprotein lipase","volume":"47","author":"Kobayashi","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"2022031210523488100_B49","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1172\/JCI200523219","article-title":"Effects of the PPAR-\u03b3 agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus","volume":"115","author":"Nagashima","year":"2005","journal-title":"J Clin Invest"},{"key":"2022031210523488100_B50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.abb.2008.05.015","article-title":"Pioglitazone induces lipid accumulation in the rat heart despite concomitant reduction in plasma free fatty acid availability","volume":"477","author":"Baranowski","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"2022031210523488100_B51","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(07)61514-1","article-title":"Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials","volume":"370","author":"Lago","year":"2007","journal-title":"Lancet"},{"key":"2022031210523488100_B52","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1001\/jama.298.22.2634","article-title":"Thiazolidinediones and cardiovascular outcomes in older patients with diabetes","volume":"298","author":"Lipscombe","year":"2007","journal-title":"JAMA"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/58\/11\/2464\/393622\/zdb01109002464.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/58\/11\/2464\/393622\/zdb01109002464.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:19:45Z","timestamp":1667405985000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/58\/11\/2464\/15273\/Cleavage-of-Protein-Kinase-D-After-Acute"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,1]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db09-0681","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,1]]}}}